Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. This is a 33.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $31.51 million which missed the analyst consensus estimate of $31.80 million by 0.90 percent. This is a 12.11 percent increase over sales of $28.11 million the same period last year.